Why Is DexCom (DXCM) Stock Rocketing Higher Today

Why Is DexCom (DXCM) Stock Rocketing Higher Today

What Happened?

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 10.9% in the morning session after the company reported strong second-quarter results and slightly raised its full-year financial outlook.

The company, which specializes in continuous glucose monitoring systems, posted revenue of $1.31 billion, up 13.1% from the previous year and surpassing analyst expectations. DexCom's profitability also showed significant improvement, with adjusted earnings per share of $0.70, beating estimates by over 15%.

This was driven by a notable expansion in its operating margin, which climbed to 24.3% from 18.4% in the same quarter last year. Looking ahead, the company nudged its full-year revenue guidance higher to a midpoint of $5.22 billion.

Is now the time to buy DexCom? Access our full analysis report here, it's free.

What Is The Market Telling Us

DexCom's shares are quite volatile and have had 15 moves greater than 5% over the last year. But moves this big are rare even for DexCom and indicate this news significantly impacted the market's perception of the business.

The biggest move we wrote about over the last year was 9 months ago when the stock dropped 14.8% on the news that the company reported underwhelming earnings. The company's revenue grew over 21% year-on-year to $1.21 billion, and its adjusted earnings per share of $0.61 also came in ahead of consensus estimates. DexCom lifted its full-year 2025 revenue forecast to approximately $4.64 billion. Despite these positive metrics, the stock's decline suggests investors were anticipating an even more robust performance and a more substantial guidance increase. The market's negative reaction indicates that the strong quarter was not enough to meet the high expectations priced into the stock, prompting a sell-off.

DexCom is up 23.5% since the beginning of the year, and at $82.20 per share, it is trading close to its 52-week high of $82.26 from August 2025. Despite the year-to-date gain, investors who bought $1,000 worth of DexCom's shares 5 years ago would now be looking at only $643.00.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you're unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

View Comments